CLS2702D
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CLS2702D, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group [Phase 3]